Are you considering talking to your healthcare provider about biosimilars or has your healthcare provider talked to you already about biosimilars? As people who live with arthritis, we put together some questions reviewed by our Medical Advisory Committee that might...
The Canadian Rheumatology Association (CRA), with input from the Canadian Arthritis Patient Alliance (CAPA) has developed a Decision Aid for the COVID-19 Vaccine in Patients with Autoimmune Rheumatic Diseases. This Decision Aid is for an adult of age >18 years...
Are you wondering what is health technology assessment (HTA)? CAPA provided input to Envision Pharma, a medical communications company, as they have developed the infographic on Health Technology Assessment. The purpose of this document is to provide a plain language...
We know there can be a lot of questions about the flu vaccine when you live with inflammatory arthritis. As people who live with arthritis, we put together some questions that our Medical Advisory Committee has answered for you here. FAQ (EN) FAQ...
CAPA has been working, along with other patient organizations and health charities, with Clinical Trials Ontario to develop information resources about clinical trials that are easy to understand and that can help people who wish to learn more about clinical trials or...
This document provides an overview of the public drug plans in each province in alphabetical order. Read more on who qualifies for the program, what the deductible, premium and co payment is, who pays for medications first and where additional information can be...
English 
Français du Canada